Trademark Overview
On Friday, December 5, 2025, a trademark application was filed for PIVLAZ with the United States Patent and Trademark Office. The USPTO has given the PIVLAZ trademark a serial number of 99531859. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Friday, December 5, 2025. This trademark is owned by Idorsia Pharmaceuticals Ltd. The PIVLAZ trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for Pharmaceutical preparations for cardiovascular, pulmonary, inflammatory indications, for the treatment of pathological incidents of the central nervous system, in particular subarachnoid hemorrhage and sequelae thereof; pharmaceutical products for the treatment of cancer